Search in:
Yung Chang
- YUNG.CHANG@asu.edu
- (480) 965-8672
- BIODESIGN BLDG A TEMPE
Professor
Faculty, TEMPE Campus, Mailcode 7301
Biography:
Dr. Yung Chang is an immunologist who studies the development and function of the immune system. She and her research team investigate the genetic recombination process that is crucial to the establishment of adaptive immunity — the immune response the body makes to specific invaders. They also investigate how alterations of this genetic process can lead to immunodeficiencies and cancers of lymphoid cells.
In addition, Dr. Chang and her collaborators have developed a new methodology to modulate immune responses. Specifically, they use DNA nanostructure to design and construct more useful vaccines and immunotherapeutic agents. They also investigate other nanomaterials, focusing on the environmental impact of these synthetics and their adverse effect on aquatic organisms.
Education:
- Ph.D. University of Iowa 1988
- M.D. Beijing Medical University 1983
Research Website URL:
Publications:
- 1. Liu., X., Y. Xu, T. Yu, C. Clifford, Y. Liu, H. Yan & Y. Chang. A DNA nanostructure platform for directed assembly of synthetic vaccines. Nano Letters (2012).
- Wang, G., K. Dhar, P. C. Swanson, M. Levitus* & Y. Chang*. Real time monitoring of RAG-catalyzed DNA cleavage unveils dynamic changes in coding end association with the post-cleavage complex. Nucleic Acids Research (2012).
- Wang, J., X. Zhu, Y. Chen & Y. Chang. Application of embryonic and adult zebrafish for nanotoxicity assessment. Methods in Molecular Biology: Nanotoxicity," Humana Press, Springer Publishing Group (2012).
- Liu, X., H. Yan, Y. Liu & Y. Chang. Targeted Cell–Cell Interactions by DNA Nanoscaffold- Templated Multivalent Bispecifi c Aptamers. Small (2011).
- Zhu, X, J. Wang, Y. Zhang, Y. Chang & Y. Chen. Trophic transfer of TiO2 nanoparticles from Daphina to zebrafish in a simplified freshwater food chain. Chemosphere (2010).
- Zhu, X., Y. Chang & Y. Chen. Toxicity and bioaccumulation of TiO2 nanoparticle aggregates in Daphnia magna. Chemosphere (2010).
- Zhu, X., Y. Chang* & Y. Chen. Toxicity and bioaccumulation of TiO2 nanoparticle aggregates in Daphnia magna. Chemosphere (2010).
- Zhu, X., J. Wang, X. Zhang, Y. Chang* & Y. Chen. Impact of ZnO nanoparticle aggregates on the embryonic development of Zebrafish (Danio rerio). Nanotechology (2009).
Research Activity:
- Chang,Yung*, Hecht,Sidney Michael, Kumar,Sudhir, Yan,Hao. Rational design and targeted selection of effective DNA-scaffolded nicotine vaccines (Chang). HHS-NIH-NIDA(4/15/2013 - 2/29/2016).
- Chang,Yung*. Anti-tumor Immunomodulating DNA-nanostructures. ASU-Mayo Seed Grant(1/1/2012 - 12/31/2012).
- Duch,Carsten Juergen*, Chang,Yung, Hogue,Brenda G, Jung,Ranu, Kusumi,Kenro, Neisewander,Janet Leigh, Newfeld,Stuart J, Smith,Brian. Acquisition of a Leica TCS SP5 Laser Scanning Confocal Microscope. HHS-NIH-NCRR(5/1/2011 - 4/30/2012).
- Chang,Yung*, Hecht,Sidney Michael, Yan,Hao. TURNABLE NICOTINE DNA-NANOVACCINES. HHS-NIH-NIDA(4/1/2011 - 3/31/2014).
- Chang,Yung*, Liu,Yan, Yan,Hao. Tunable DNA-nanostructure to Induce NK-mediated Killing of Tumor Cells. HHS-NIH-NCI(5/1/2010 - 4/30/2013).
- Chang,Yung*. Overcoming Drug Resitance in Breast Cancer Stem Cells (BCSC). MAYO CLINIC SCOTTSDALE(1/1/2010 - 12/31/2010).
- Chang,Yung*, Liu,Yan, Yan,Hao. Multi-Specific aptamer-nanoscaffolds to induce aptamer-dependent cellualr cytotoxicity (ApDCC) against breast cancer cells. DOD-ARMY-USAMRAA(9/15/2009 - 1/14/2011).
- Chen,Julian J-L*, Chen,Julian J-L*, Chang,Yung. Development fo a fish model for dyskeratosis congenita and cancer research. HHS-NIH-NCRR(9/15/2008 - 6/30/2010).
- Jacobs,Bertram Lewis*, Chang,Yung. Disabling Vaccinia IFNr: A New Smallpox Vaccine. HHS-NIH-NIAID(7/1/2008 - 12/31/2010).
- Chang,Yung*. Novel Cellular Model to Study Chromosome Abnormality. MAYO CLINIC SCOTTSDALE(1/1/2008 - 12/31/2009).
- Jacobs,Bertram Lewis*, Chang,Yung. Disabling Vaccinia IFNr: A New Smallpox Vaccine. HHS-NIH-NIAID(7/1/2007 - 6/30/2010).
- Chang,Yung*. Surface Phenotyping ofEndotheliz Progenitors Isolated from PBL. VA-Hayden Center(7/1/2007 - 6/30/2008).
- Chen,Yongsheng*, Chang,Yung, Hu,Qiang, Sommerfeld,Milton R. Methodology Development for Manufactured Nanomaterial Bioaccumulation Test. USEPA-REGION 9(5/1/2007 - 4/30/2010).
- Jacobs,Bertram Lewis*, Chang,Yung. Disabling Vaccinia IFNr: A New Smallpox Vaccine. HHS-NIH-NIAID(7/1/2006 - 6/30/2009).
- Petuskey,William T*, Chang,Yung, Daniel,Douglas, Fromme,Petra, Gould,Ian R, Gust,John Devens, Lin,Su, Liu,Yan, Moore,Ana L, Moore,Thomas Andrew, Roberson,Robert Wayne, Vermaas,Willem F J, Wachter,Rebekka M, Webber,Andrew Neil, Wei,Qihuo, Woodbury,Neal Walter, Yan,Hao, Zenhausern,Frederic, Zenhausern,Frederic. Purchase of an Instrument for Ultrafast, Multidimensional Fluorescence Detection and Imaging. NSF-MPS-CHE(2/15/2006 - 1/31/2009).
- Jacobs,Bertram Lewis*, Chang,Yung. Disabling Vaccinia IFNr: A New Smallpox Vaccine. HHS-NIH-NIAID(7/10/2005 - 6/30/2006).
- Chang,Yung*, Brophy,Colleen M, Jacobs,Bertram Lewis, Misra,Rajeev, Pettit,George Robert, Sierks,Michael Richard, Zautra,Alex John. THE BD FACSARIA, A NEW FLOW CYTOMETER SORTER. HHS-NIH-NCRR(4/1/2004 - 3/31/2005).
- Chang,Yung*. NICOTINE REGULATION OF T CELL DEVELOPMENT. UNIV OF AZ(9/30/2003 - 1/31/2008).
- Chang,Yung*. EVALUATION OF ECHINACEA: ITS TOXICITY AND IMMUNE MODULATION. GAIA HERBS(1/2/2003 - 12/31/2005).
- Schmidt,Jean M*, Chang,Yung. IN VIVO EFFICACY EVALUATION OF NEW ANTICANCER DRUGS. ABRC(7/1/2002 - 6/30/2003).
- Schmidt,Jean M*, Chang,Yung. IN VIVO EFFICACY EVALUATION OF NEW ANTICANCER DRUGS. ABRC(7/1/2001 - 6/30/2002).
- Schmidt,Jean M*, Chang,Yung. IN VIVO EFFICACY EVALUATION OF NEW ANTICANCER DRUGS. ABRC(7/1/2000 - 6/30/2001).
- Chang,Yung*. MICROFLUIDS DEVISE FOR DIAGNOSIS OF NOSOCOMIAL AGENTS. MOTOROLA, INC(11/1/1999 - 10/31/2002).
- Chang,Yung*. EFFECT OF VDJ RECOMBINATION ON SCID B CELL DEVELOPMENT. HHS-NIH-NCI(9/1/1998 - 12/31/2009).
- Chang,Yung*. DNA CHIP DEVELOPMENT. MOTOROLA, INC(7/1/1997 - 6/30/2004).
| Summer 2022 | |
|---|---|
| Course Number | Course Title |
| BDE 792 | Research |
| Spring 2022 | |
|---|---|
| Course Number | Course Title |
| BIO 420 | Immun: Molecular&Cell Foundtns |
| MIC 420 | Immun: Molecular&Cell Foundtns |
| BIO 492 | Honors Directed Study |
| BIO 493 | Honors Thesis |
| BIO 495 | Undergraduate Research |
| MBB 495 | Undergraduate Research |
| MIC 598 | Special Topics |
| MCB 598 | Special Topics |
| BDE 792 | Research |
| BDE 795 | Continuing Registration |
| BDE 799 | Dissertation |
| Fall 2021 | |
|---|---|
| Course Number | Course Title |
| BIO 492 | Honors Directed Study |
| MIC 495 | Undergraduate Research |
| BIO 495 | Undergraduate Research |
| Summer 2021 | |
|---|---|
| Course Number | Course Title |
| BDE 792 | Research |
| Spring 2021 | |
|---|---|
| Course Number | Course Title |
| BIO 420 | Immun: Molecular&Cell Foundtns |
| MIC 420 | Immun: Molecular&Cell Foundtns |
| BIO 492 | Honors Directed Study |
| BIO 493 | Honors Thesis |
| BIO 495 | Undergraduate Research |
| MBB 495 | Undergraduate Research |
| MIC 598 | Special Topics |
| MCB 598 | Special Topics |
| BDE 792 | Research |
| BDE 799 | Dissertation |
| Fall 2020 | |
|---|---|
| Course Number | Course Title |
| BIO 492 | Honors Directed Study |
| MIC 495 | Undergraduate Research |
| BIO 495 | Undergraduate Research |
| Summer 2020 | |
|---|---|
| Course Number | Course Title |
| BDE 792 | Research |
| Spring 2020 | |
|---|---|
| Course Number | Course Title |
| BIO 492 | Honors Directed Study |
| BIO 493 | Honors Thesis |
| MBB 495 | Undergraduate Research |
| BIO 495 | Undergraduate Research |
| BDE 792 | Research |
| BDE 799 | Dissertation |
| Fall 2019 | |
|---|---|
| Course Number | Course Title |
| BIO 492 | Honors Directed Study |
| MIC 493 | Honors Thesis |
| MIC 495 | Undergraduate Research |
| BIO 495 | Undergraduate Research |
| Spring 2019 | |
|---|---|
| Course Number | Course Title |
| BIO 420 | Immun: Molecular&Cell Foundtns |
| MIC 420 | Immun: Molecular&Cell Foundtns |
| BIO 492 | Honors Directed Study |
| BIO 493 | Honors Thesis |
| BIO 495 | Undergraduate Research |
| MBB 495 | Undergraduate Research |
| MIC 598 | Special Topics |
| MCB 598 | Special Topics |
| BDE 792 | Research |
| BDE 799 | Dissertation |
| Fall 2018 | |
|---|---|
| Course Number | Course Title |
| BIO 492 | Honors Directed Study |
| MIC 493 | Honors Thesis |
| MIC 495 | Undergraduate Research |
| Spring 2018 | |
|---|---|
| Course Number | Course Title |
| MIC 420 | Immun: Molecular&Cell Foundtns |
| BIO 420 | Immun: Molecular&Cell Foundtns |
| BIO 492 | Honors Directed Study |
| BIO 493 | Honors Thesis |
| BIO 495 | Undergraduate Research |
| MBB 495 | Undergraduate Research |
| MIC 598 | Special Topics |
| MCB 598 | Special Topics |
| Fall 2017 | |
|---|---|
| Course Number | Course Title |
| BIO 492 | Honors Directed Study |
| MIC 493 | Honors Thesis |
| MIC 495 | Undergraduate Research |
Presentations:
- Tania Lebratti, Xiaowei Liu, Xianbin Yang, and Yung Chang. DNA Nanoparticles as Stable Programmable Carriers of siRNA. 2014 Annual Biomedical Research Conference for Minority Students (ABRCMS) (Nov 2014).
- Joseph Leal, Xiaowei Liu, and Yung Chang. Application of DNA-scaffolded Vaccines for Treatment of Nicotine Addiction and Cancer. 2014 Annual Biomedical Research Conference for Minority Students (ABRCMS) (Nov 2014).
- Yung Chang. Programmable DNA-Nanoscaffolds for Vaccine Design. 2014 National Biotechnology Conference (NBC), organized by American Association of Pharmaceutical Sc (May 2014).
- Xiaowei Liu, Lili Wang, Joseph Leal, and Yung Chang. Development of DNA nanoscaffolded nicotine vaccine complex. 2014 National Biotechnology Conference (NBC), organized by American Association of Pharmaceutical Sc (May 2014).
- Yung Chang. DNA-directed Programmable Vaccines. BIT’s 6th Annual World Congress of Vaccines (Apr 2014).
- Xiaowei Liu, Joseph Leal, Hao Yan, Yan Liu & Yung Chang. Construction of DNA Nanoscaffolded Nicotine Vaccine Complex. B Cell Development and Function - Keystone Symposia (Feb 2013).
- Kevin Bushway, Guannnan Wang, Katherine Noonan, Marcia Levitus & Yung Chang. Real time analysis of RAG-DNA interactions during normal and aberrant recombination reactions. B Cell Development and Function - Keystone Symposia (Feb 2013).
- Liu, X. T. Yu, H. Yan, Y. Liu & Y. Chang. Exploring DNA nanostructures for vaccine development. DNA 17 17th International Conference on DNA Computing and Molecular Programming (Sep 2011).
- Chang, Y., Liu, X. H. Yan, Y. Liu &. Targeted Cell-Cell Interactions by DNA Nanoscaffold-Templated Multivalent Bi-specific Aptamers. DOD Breast Cancer Research Program’s 2011 Era of Hope Conference (Aug 2011).
- Yung Chang. Novel NIH DNA-origami nanovaccines. NIDA Avant-Garde Presentation as one of five candidates invited for full application (Jun 2011).
- Wang, Ja, X. Zhua, X. Zhang, Z. Zhao, H. Liu, R. George, J. Wilson-Rawls. Y. Chang and Y. Chen. Are TiO2 nanoparticles safe? Disruption of zebrafish (Danio reior) reproduction upon chronic exposure to low concentrations of TiO2 nanoparticles. highlighted in a feature story Chemical & Engineering News, the weekly magazine of the American Chem (Mar 2011).
- Wang, G. M. Levitus, P. C. Swanson & Y. Chang. Real-time Monitoring of Rag-catalyzed Recombination Cleavage. Keystone Symposia (Jan 2011).
- Ananieva, Olga, Chang, Yung. Ribotoxic properties of an novel immunomodulatory compound sodium narcistatin. Signaling & Gene Expression in the Immune System (Cold Spring Harbor Symposia) (Apr 2006).
- Zhi, Li, Zhong, Hanbing, Shuo, Lin, Chang, Yung. Initiation of V(D)J recombinaiton in Zebrafish Ovaries. Signaling & Gene Expression in the Immune System (Cold Spring Harbor Symposia) (Apr 2006).
- Franco, Daniel, Chang, Yung. Accessibility of V(D)J recombination endsd during DNA break resolution. International Congress of Immunology (Jul 2004).
Service:
- NIH-NIAID: Partnerships for Biodefense (RO1) RFA-A1-13-013, Reviewer (2013 - Present)
- Journal of the American Chemical Society, Reviewer (2013 - Present)
- Journal of Immunology, Reviewer (2013 - Present)
- Advances in Pharmacology, Reviewer (2013 - Present)
- RESEARCH CORPORATION FOR SCIENCE ADVANCEMENT (http://www.rescorp.org/grants-and-awards), Reviewer (2013 - Present)
- NIH-SIG-S10 Study section, Reviewer (2013 - Present)
- NIDA-Cutting-Edge Basic Research Awards (CEBRA), Reviewer (2013 - Present)
- Small, Reviewer (2013 - Present)
- American Federation for Aging Research (AFAR), Reviewer (2013 - Present)
- Cell Reports, Reviewer (2013 - Present)
- Journal of the American Chemical Society, Reviewer (2010 - Present)
- NSF, Reviewer (2010 - Present)
- AFAR, REviewer (2010 - Present)
- Nanomedicine, Reviewer (2010 - Present)
- Flow Cytometry Core Facility, Overseeing the Core Facility (2013 - 2013)
- IACUC, member (2013 - 2013)
- Animal User Advisory Committee, Member (2013 - 2013)
- Radiation Safety Committee, member (2013 - 2013)
- GACR (Czech Science Foundation), Reviewer (2012 - 2012)
- Nucleic Acids Research, ad hoc reviewer (2012 - 2012)
- NIH-CEBRA (NIDA Cutting-Edge Basic Research Award) R21, Reviewer (2012 - 2012)
- AFAR, Review (2012 - 2012)
- NIH " Partnerships for Development of Vaccine Technologies", member of the Study Section (2012 - 2012)
- NIH-S10 Instrumentation Grant Program, member of the Study Section (2012 - 2012)
- AUAC, Member (2009 - 2012)
- IACUC, Member (2009 - 2012)
- Radiation Protection Committee, Member (2009 - 2012)
- Journal of Hazardous Materials, ad hoc reviewer (2012 - 2012)
- AFAR, reviewer (2011 - 2011)
- FACS Service Facility, Coordinator (2005 - 2011)
- NIH, NCRR study section (2010 - 2011)
- Adjunct Faculty Committee, Member (2006 - 2011)
- Journal of biological chemistry, Reviewer (2008 - 2008)
- NIH, reviewer (2008 - 2008)
- Journal of Immunology, Reviwer (2008 - 2008)
- Journal of Histochemistry, Reviewer (2008 - 2008)
- American Federation for Againg Research, Reviewer (2008 - 2008)
- NSF, Reviewer (2008 - 2008)
- Trends in Medicine, reviewer (2008 - 2008)
Expertise Areas: